Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by DREISMANN HEINRICH, Director. Officer active across 1 company, notably Myriad Genetics INC. Cumulatively, 3 filings have been recorded. History available since 3 June 2021. The latest transaction was disclosed on 2 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Heinrich Dreismann is a Board Member at Myriad Genetics Inc. He brings expertise in genetic testing and health solutions. His role involves overseeing strategic initiatives and evaluating growth opportunities. Heinrich plays an important role in guiding the company's decisions regarding health innovations.